| Literature DB >> 29763602 |
Michael A Cooper1, Blaise W Menta1, Consuelo Perez-Sanchez2, Megan M Jack3, Zair W Khan1, Janelle M Ryals1, Michelle Winter4, Douglas E Wright5.
Abstract
Current experiments investigated whether a ketogenic diet impacts neuropathy associated with obesity and prediabetes. Mice challenged with a ketogenic diet were compared to mice fed a high-fat diet or a high-fat diet plus exercise. Additionally, an intervention switching to a ketogenic diet following 8 weeks of high-fat diet was performed to compare how a control diet, exercise, or a ketogenic diet affects metabolic syndrome-induced neural complications. When challenged with a ketogenic diet, mice had reduced bodyweight and fat mass compared to high-fat-fed mice, and were similar to exercised, high-fat-fed mice. High-fat-fed, exercised and ketogenic-fed mice had mildly elevated blood glucose; conversely, ketogenic diet-fed mice were unique in having reduced serum insulin levels. Ketogenic diet-fed mice never developed mechanical allodynia contrary to mice fed a high-fat diet. Ketogenic diet fed mice also had increased epidermal axon density compared all other groups. When a ketogenic diet was used as an intervention, a ketogenic diet was unable to reverse high-fat fed-induced metabolic changes but was able to significantly reverse a high-fat diet-induced mechanical allodynia. As an intervention, a ketogenic diet also increased epidermal axon density. In vitro studies revealed increased neurite outgrowth in sensory neurons from mice fed a ketogenic diet and in neurons from normal diet-fed mice given ketone bodies in the culture medium. These results suggest a ketogenic diet can prevent certain complications of prediabetes and provides significant benefits to peripheral axons and sensory dysfunction. Published by Elsevier Inc.Entities:
Keywords: DRG; Diabetes; Exercise; High-fat; Ketogenic; Ketones; Mice; Pain
Mesh:
Substances:
Year: 2018 PMID: 29763602 PMCID: PMC5994385 DOI: 10.1016/j.expneurol.2018.05.011
Source DB: PubMed Journal: Exp Neurol ISSN: 0014-4886 Impact factor: 5.330